Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7145 results

Big pharma increasingly collaborating with Indian companies

26-11-2014

Even as multinational pharma majors are looking for new ways to squeeze costs along the whole value chain,…

IndiaLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalRussia

Initiative to support and enhance medicine quality assurance in Latin American/Caribbean

26-11-2014

Representatives from 16 Latin American and Caribbean countries laid the foundation for a regional mechanism…

PharmaceuticalRegulationSouth America

UK behind European average in companies' ability to protect sensitive information

UK behind European average in companies' ability to protect sensitive information

26-11-2014

The UK is lagging behind other European companies in terms of protecting sensitive information, responding…

EuropeIron MountainLegalPharmaceuticalUnited Kingdom

Amgen/AstraZeneca's brodalumab trial meets primary endpoints for moderate-to-severe plaque psoriasis

Amgen/AstraZeneca's brodalumab trial meets primary endpoints for moderate-to-severe plaque psoriasis

26-11-2014

USA-based Amgen, the world’s leading independent biotech firm, and Anglo-Swedish drug major AstraZeneca…

AmgenAstraZenecabrodalumabDermatologicalsPharmaceuticalResearch

Eli Lilly's Trulicity approved in the EU for type 2 diabetes

Eli Lilly's Trulicity approved in the EU for type 2 diabetes

26-11-2014

US drug major Eli Lilly has received approval from the European Commission for its GLP-1 receptor agonist…

DiabetesEli LillyEuropePharmaceuticalRegulationTrulicity

Apellis Pharma to acquire former parent Potentia

26-11-2014

USA-based Apellis Pharmaceuticals has entered into an agreement to acquire Potentia Pharmaceuticals,…

Apellis PharmaceuticalsMergers & AcquisitionsOphthalmicsPharmaceuticalPotentia Pharmaceuticals

Global oncology market to hit $109 billion in 2020

26-11-2014

Cancer, with a death toll exceeding that of AIDS (acquired immune deficiency syndrome), tuberculosis…

AvastinCelgene Corp.GlobalMarkets & MarketingMergers & AcquisitionsNovartisOncologyPharmaceuticalResearchRevlimidRoche

FDA adds warning to Tecfidera label after patient death

FDA adds warning to Tecfidera label after patient death

26-11-2014

The US Food and Drug Administration has issued a warning that a patient with multiple sclerosis who was…

Biogen IdecCNS DiseasesPharmaceuticalRegulationTecfideraUSA

Eisai opens £8 million packaging facility in UK

26-11-2014

Japanese drug major Eisai has opened a new facility at its EMEA Knowledge Center in Hatfield, UK, to…

EisailenvatinibPharmaceuticalProductionUK

NICE updated guidance backs Novartis’ Glivec for GIST

26-11-2014

UK health costs watchdog the National Institute for Health and Care Excellence (NICE) has issued final…

GlivecNovartisOncologyPharmaceuticalPricingRegulationUK

UK's NICE recommends Selincro to help reduce alcohol dependence

UK's NICE recommends Selincro to help reduce alcohol dependence

26-11-2014

The UK’s National Institute for Health and Care Excellence (NICE) has recommended Selincro (nalmefene)…

LundbeckNeurologicalPharmaceuticalRegulationSelincroUK

Merck & Co submits first regulatory filing for omarigliptin, in Japan

Merck & Co submits first regulatory filing for omarigliptin, in Japan

25-11-2014

US pharma giant Merck & Co has submitted a new drug application for omarigliptin, its investigational…

DiabetesJapanMerck & CoomarigliptinPharmaceuticalRegulation

Janssen submits NDA for Yondelis in soft tissue sarcoma

Janssen submits NDA for Yondelis in soft tissue sarcoma

25-11-2014

US health care giant Johnson & Johnson’s subsidiary Janssen Research & Development has submitted a…

Janssen Research and DevelopmentOncologyPharmaceuticalRegulationUSAYondelis

Predictive biomarkers could help costly cancer drugs secure market access

25-11-2014

Biomarker driven prescribing is likely to positively influence perceptions of oncology drugs for both…

EuropeMarkets & MarketingOncologyPharmaceuticalPricing

AstraZeneca plans further Russian expansion

25-11-2014

Anglo-Swedish pharma major AstraZeneca plans to continue active development on the Russian pharmaceutical…

AstraZenecaFinancialPharmaceuticalProductionRussia

Acute myeloid leukemia treatment market will grow to $878.6 million by 2020

Acute myeloid leukemia treatment market will grow to $878.6 million by 2020

25-11-2014

The global acute myeloid leukemia therapeutics market is predicted to increase from $632.6 million in…

GlobalMarkets & MarketingmidostaurinOncologyPharmaceuticalquizartinib

Russian government predicts bright prospects to national pharma industry

Russian government predicts bright prospects to national pharma industry

25-11-2014

The Russian pharmaceutical industry is booming, despite the economic recession in the country and devaluation…

Markets & MarketingPharmaceuticalPricingRegulationRussia

HIV therapy Rezolsta approved by EC

HIV therapy Rezolsta approved by EC

25-11-2014

Belgium-based Janssen-Cilag International NV, a subsidiary of US health care giant Johnson & Johnson,…

Anti-viralsEuropeJanssen-CilagPharmaceuticalPrezistaRegulation

Novartis' Signifor approved in EU for acromegaly patients

Novartis' Signifor approved in EU for acromegaly patients

25-11-2014

The European Commission has approved Swiss drug major Novartis’ Signifor (pasireotide) for patients…

NovartisPharmaceuticalRare diseasesRegulationSigniforSwitzerland

AstraZeneca’s Duaklir Genuair approved in the EU for COPD

AstraZeneca’s Duaklir Genuair approved in the EU for COPD

25-11-2014

The European Commission has granted marketing authorization for Anglo-Swedish pharma major AstraZeneca’s…

AstraZenecaDuaklir GenuairPharmaceuticalRegulationRespiratory and PulmonaryUK

US FDA pushes back decision date for Novartis’ panobinostat

US FDA pushes back decision date for Novartis’ panobinostat

25-11-2014

The US Food and Drug Administration has extended its priority review period by up to three months for…

FarydakNovartisOncologypanobinostatPharmaceuticalRegulationUSA

BioMarin to acquire Prosensa for up to $840 million

BioMarin to acquire Prosensa for up to $840 million

24-11-2014

US drugmaker BioMarin Pharmaceutical has entered into a definitive agreement to purchase all of the outstanding…

BioMarin PharmaceuticaldrisapersenMergers & AcquisitionsPharmaceuticalProsensaRare diseases

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

24-11-2014

Trimel Biopharma, a subsidiary of Canada's Trimel Pharmaceuticals Corp, has signed an agreement with…

CanadaEndoLicensingMarkets & MarketingMen's HealthPharmaceuticalTrimel PharmaceuticalsUSA

Roche and Lundbeck at the Jefferies 2014 Global Healthcare Conference

Roche and Lundbeck at the Jefferies 2014 Global Healthcare Conference

24-11-2014

Pharma, biotech and health care companies convened in London last week to update investors at the Jefferies…

FinancialHealth Medical PharmaPharmaceuticalRocheUK

1 to 25 of 7145 results

Parexel

Parexel

Back to top